Cover Image

Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation

Isocitrate dehydrogenase 1 (IDH1) mutations are associated with improved survival in gliomas. Depending on the IDH1 status, TERT promoter mutations affect prognosis. IDH1 mutations are associated with alpha-thalassemia/mental retardation syndrome X-linked (ATRX) mutations and alternative lengthening...

Full description

Saved in:
Bibliographic Details
Main Authors: Ventura Ferreira, Mónica Sofia (Author) , Sørensen, Mia Dahl (Author) , Pusch, Stefan (Author) , Beier, Dagmar (Author) , Bouillon, Anne-Sophie (Author) , Kristensen, Bjarne Winther (Author) , Brümmendorf, Tim Henrik (Author) , Beier, Christoph-Patrick (Author) , Beier, Fabian (Author)
Format: Article (Journal)
Language:English
Published: 20 January 2020
In: Journal of neuro-oncology
Year: 2020, Volume: 147, Issue: 1, Pages: 1-14
ISSN:1573-7373
DOI:10.1007/s11060-020-03394-y
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s11060-020-03394-y
Get full text
Author Notes:Monica Sofia Ventura Ferreira, Mia Dahl Sørensen, Stefan Pusch, Dagmar Beier, Anne-Sophie Bouillon, Bjarne Winther Kristensen, Tim Henrik Brümmendorf, Christoph Patrick Beier, Fabian Beier
Description
Summary:Isocitrate dehydrogenase 1 (IDH1) mutations are associated with improved survival in gliomas. Depending on the IDH1 status, TERT promoter mutations affect prognosis. IDH1 mutations are associated with alpha-thalassemia/mental retardation syndrome X-linked (ATRX) mutations and alternative lengthening of telomeres (ALT), suggesting an interaction between IDH1 and telomeres. However, little is known how IDH1 mutations affect telomere maintenance.
Item Description:Gesehen am 14.04.2020
Physical Description:Online Resource
ISSN:1573-7373
DOI:10.1007/s11060-020-03394-y

Similar Items